These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39051070)

  • 1. [Euonymus alatus delays progression of diabetic kidney disease in mice by regulating EGFR tyrosine kinase inhibitor resistance signaling pathway].
    Wang J; Cui W; Dou X; Yin B; Niu Y; Niu L; Yan G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jul; 44(7):1243-1255. PubMed ID: 39051070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of Zicui Decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking].
    Gao LD; Liu J; Huang YH; Wang BH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3339-3347. PubMed ID: 35851128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.
    Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
    Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology and molecular dynamics study of the effect of the
    Zhang MY; Zheng SQ
    World J Diabetes; 2024 Jul; 15(7):1562-1588. PubMed ID: 39099827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
    Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
    Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the possible mechanism(s) underlying the nephroprotective effect of Zhenwu Decoction in diabetic kidney disease: An integrated analysis.
    Liu Z; Shang Q; Li H; Fang D; Li Z; Huang Y; Zhang M; Ko KM; Chen J
    Phytomedicine; 2023 Oct; 119():154988. PubMed ID: 37523837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the mechanism of hirudin in the treatment of diabetic kidney disease using network pharmacology combined with molecular docking verification.
    Xinxin P; Qing Z; Zining P; Yage Z; Xiujie S; Jiarui H
    J Tradit Chin Med; 2022 Aug; 42(4):586-594. PubMed ID: 35848975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
    Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
    J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway.
    Mao J; Lu Q; Gao F; Liu H; Tan J
    J Vis Exp; 2024 May; (207):. PubMed ID: 38801274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of
    Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
    Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
    [No Abstract]   [Full Text] [Related]  

  • 14. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
    He L; Shen K; He L; Chen Y; Tang Z
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
    Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
    Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
    Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
    Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the pharmacological mechanisms of
    Lu M; Ou J; Deng X; Chen Y; Gao Q
    Heliyon; 2023 Jun; 9(6):e17550. PubMed ID: 37416640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology analysis and molecular docking using the Chinese herbal agent WYHX formula (according to Yan Dexin): Management of coronary artery disease.
    Wang ZY; Zhou M; Sun YN; Hu XZ
    Int J Clin Pharmacol Ther; 2024 Aug; 62(8):363-376. PubMed ID: 38916485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.